Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05963711

The Genital Microbiome of Male Partners of Women with Recurrent BV Undergoing Vaginal Microbiome Transplantation

The Penile Microbiome in Partners of Women with Recurrent BV and Its Response to Decolonization Protocol

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

There is strong observational evidence that sexual activity plays a key role in Bacterial Vaginosis (BV) acquisition and recurrence. Microbiological data support the contribution of sexual transmission to the pathogenesis of BV through the exchange of BV-associated bacteria (BVAB) between sexual partners. Although BV epidemiology strongly suggests sexual transmission, treatment of sexual partners is not recommended, based on prior treatment studies of male partners of women with recurrent BV, which showed no benefit with male treatment. Nevertheless, male condom use is highly protective against recurrent BV. This study aims to evaluate the male-partner's genital microbiome as a potential source of BV-recurrence in women undergoing vaginal microbiota transplantation (NCT04517487), and whether disinfection can eliminate BV-associated penile microbiome.

Conditions

Interventions

TypeNameDescription
OTHERchlorhexidine gluconate 4%In case BV associated bacteria will be identified (using molecular sequencing) in male samples, decolonization attempt will be conducted, using a daily wash for 5 days with chlorhexidine gluconate 4%. Following decolonization attempt, male participants will undergo re- sampling, to assess for microbiome changes. In case there is no change in microbial composition, partners will be instructed to repeat decolonization protocol, and apply a 2 cm diameter volume of 2% clindamycin cream topically to the head of the penis and upper shaft (under the foreskin if uncircumcised) twice daily for seven days following repeated decolonization. Re-sampling will follow.

Timeline

Start date
2022-10-17
Primary completion
2025-12-01
Completion
2026-06-01
First posted
2023-07-27
Last updated
2025-03-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05963711. Inclusion in this directory is not an endorsement.